Titan Biotech Ltd Share Price
(524717)
₹476.25
as on 04:01PM, 25 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 5.97 % |
3 Month Return | -34.96 % |
1 Year Return | -6.44 % |
Market Stats | |
Previous Close | ₹498.60 |
Open | ₹504.00 |
Volume | 9,268.00 |
Upper Circuit | ₹598.30 |
Lower Circuit | ₹398.90 |
Market Cap | ₹393.56Cr |
P/E Ratio
17.51
PEG Ratio
-6.02
Market Cap
₹393.56 Cr
P/B Ratio
3.4
EPS
28.64
Dividend Yield
0.38
Sector
Pharmaceuticals
ROE
20.18
Titan Biotech Reports Decline in Sales and Profit - 17 Feb, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Unchanged
Promoters holdings remained unchanged at 55.88% of holdings in Mar 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 49.7% return, outperforming this stock by 56.1%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 136.8% return, outperforming this stock by 53.6%
Revenue Fall
Revenue is down for the last 3 quarters, 43.74 Cr → 39.87 Cr (in ₹), with an average decrease of 4.5% per quarter
Price Dip
In the last 3 months, Titan Biotech stock has moved down by -35.0%
Profit Down
Netprofit is down for the last 2 quarters, 6.7 Cr → 4.39 Cr (in ₹), with an average decrease of 34.5% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 44.12% to 44.11% in Mar 2025 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 55.88% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 44.11% | 0.00 | |
Others | 0.01% | 0.00 |
Titan Biotech Ltd in the last 5 years
Lowest (3.20x)
June 30, 2020
Today (17.51x)
April 25, 2025
Industry (55.10x)
April 25, 2025
Highest (32.11x)
October 21, 2024
Titan Biotech Ltd’s net profit fell -38.77% since last year same period to ₹4.39Cr in the Q3 2024-2025. On a quarterly growth basis, Titan Biotech Ltd has generated -34.48% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Titan Biotech Ltd has declared dividend of ₹2 - translating a dividend yield of 0.80%.
Read More about DividendsBearish
Neutral
Bullish
Titan Biotech Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹393.56 Cr | 173.4% | 0.54 | ₹23 Cr | ₹164 Cr | |
NA | ₹176.05 Cr | 112.66% | 0.58 | NA | NA | |
NA | ₹3,647.59 Cr | 86.44% | 0.70 | ₹86 Cr | ₹806 Cr | |
BUY | ₹15,780.76 Cr | 541.45% | 0.54 | ₹300 Cr | ₹1,558 Cr | |
NA | ₹555.40 Cr | 45.07% | 0.56 | ₹13 Cr | ₹154 Cr |
Organisation | Titan Biotech Ltd |
Headquarters | New Delhi |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Titan Biotech Ltd share price today stands at ₹476.25, Open: ₹504, Previous Close: ₹498.6, High: ₹504, Low: ₹460.25, 52 Week High: ₹1017.85, 52 Week Low: ₹406.7.
Today's traded volume of Titan Biotech Ltd(524717) is 9,268.00.
Today's market capitalisation of Titan Biotech Ltd(524717) is ₹393.56Cr.
Titan Biotech Ltd (524717) share price is ₹476.25. It is down -53.21% from its 52 Week High price of ₹1017.85
Titan Biotech Ltd (524717) share price is ₹476.25. It is up 17.10% from its 52 Week Low price of ₹406.7